All Insights
Showing 157 - 168 of 792
Telecoms
UK Upper Tribunal provides renewal guidance for licence agreements
Where a licence agreement is assigned, the new operator can initiate a renewal
Regulatory and compliance
Dutch businesses need to comply with the new European Product Safety Regulation
What does the new regulation mean for companies and how will it be enforced in the Netherlands?
Artificial intelligence
Are major changes to copyright law coming to boost UK development of AI models?
Government proposes changing copyright law to facilitate use of web-scraped content for AI development, and monetisation of content by copyright
Technology, Media and Telecommunications (TMT)
DMCCA consultations launched on implementation of UK consumer protection regime
Further clarity will assist compliance with the new regimes on fake reviews, drip pricing and subscription contracts
Energy and Energy Transition
What are the advantages of using international arbitration to resolve energy project disputes?
Arbitration offers an effective resolution mechanism for disputes that are often complex, sensitive and cross-border
Life Sciences and Healthcare
Is the MHRA creating the right conditions to encourage UK investment in AI products?
Businesses bringing AI to market need to be aware of public policy and commercial factors driving regulatory reform
Regulatory Outlook
Advertising and marketing | UK Regulatory Outlook November 2024
Government introduces Tobacco and Vapes Bill to Parliament: advertising aspects | ASA publishes update on its vaping project review |
Retail and Consumer
Black Friday and competition law: compliance top tips and errors to avoid in the UK and EU
Retailers and brands must also navigate competition law and sustainability concerns around the November shopping event
Regulatory and compliance
Are you prepared for the forthcoming changes on prompt payment terms for public tendering in the UK?
Failure to comply with measures will mean companies cannot participate in central government procurements over £5 million
Life Sciences and Healthcare
Investment control in transactions in the life sciences and healthcare sector
Investment control means that additional regulatory approvals are required, affecting the timeline, complexity and costs of a transaction
Corporate
UK directors' duties: IOD issues guidance on the importance of sustainable business practice
New voluntary code of conduct provides helpful steer to directors – especially with regard to 'responsible business'
Life Sciences and Healthcare
Life sciences dealmakers need to anticipate sector-specific factors in European M&A
European regulatory and intellectual property complexities must be addressed when engaging in mergers and acquisitions
